US EditionKoss Olinger Consulting LLC Takes $235,000 Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Koss Olinger Consulting LLC Takes $235,000 Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Koss Olinger Consulting LLC purchased a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 370 shares of the biopharmaceutical company’s stock, valued at approximately $235,000. Other hedge funds have also added to or […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
